We have provided a historical perspective on a body of steroid receptor research dealing with the structure and physiological significance of the untransformed 9S receptor that has often confused both novice and expert investigators. The frequent controversies and equivocations of earlier studies were due to the fact that the native, hormone-free state of these receptors is a large multiprotein complex that resisted description for many years because of its unstable and dynamic nature. The untransformed 9S state of the steroid and dioxin receptors has provided a unique system for studying the function of the ubiquitous, abundant, and conserved heat shock protein, hsp90. The hormonal control of receptor association with hsp90 provided a method of manipulating the receptor heterocomplex in a manner that was physiologically meaningful. For several steroid receptors, binding to hsp90 was required for the receptor to be in a native hormone-binding state, and for all of the receptors, hormone binding promoted dissociation of the receptor from hsp90 and conversion of the receptor to the DNA-binding state. Although the complexes between tyrosine kinases and hsp90 were discovered earlier, the hormonal regulation or steroid receptor association with hsp90 permitted much more rapid and facile study of hsp90 function. The observations that hsp90 binds to the receptors through their HBDs and that these domains can be fused to structurally different proteins bringing their function under hormonal control provided a powerful linkage between the hormonal regulation of receptor binding to hsp90 and the initial step in steroid hormone action. Because the 9S receptor hsp90 heterocomplexes could be physically stabilized by molybdate, their protein composition could be readily studied, and it became clear that these complexes are multiprotein structures containing a number of unique proteins, such as FKBP51, FKBP52, CyP-40, and p23, that were discovered because of their presence in these structures. Further analysis showed that hsp90 itself exists in a variety of native multiprotein heterocomplexes independent of steroid receptors and other 'substrate' proteins. Cell-free systems can now be used to study the formation of receptor heterocomplexes. As we outlined in the scheme of Fig. 1, the multicomponent receptor-hsp90 heterocomplex assembly system is being reconstituted, and the importance of individual proteins, such as hsp70, p60, and p23, in the assembly process is becoming recognized. It should be noted that our understanding of the mechanism and purpose of steroid receptor heterocomplex assembly is still at an early stage. We can now speculate on the roles of receptor-associated proteins in receptor action, both as individuals and as a group, but their actual functions are still vague or unknown. We can make realistic models about the chaperoning and trafficking of steroid receptors, but we don't yet know how these processes occur, we don't know where chaperoning occurs in the cell (e.g. Is it limited to the cytoplasm? Is it a diffuse process or does chaperoning occur in association with structural elements?), and, with the exception of the requirement for hormone binding, we don't know the extent to which the hsp90-based chaperone system impacts on steroid hormone action. It is not yet clear how far the discovery of this hsp90 heterocomplex assembly system will be extended to the development of a general understanding of protein processing in the cell. Because this assembly system is apparently present in all eukaryotic cells, it probably performs an essential function for many proteins. The bacterial homolog of hsp90 is not an essential protein, but hsp90 is essential in eukaryotes, and recent studies indicate that the development of the cell nucleus from prokaryotic progenitors was accompanied by the duplication of genes for hsp90 and hsp70 (698). (ABSTRACT TRUNCATED)

/pdf/steroid-receptor-interactions-with-heat-shock-protein-and-1iq19twpoc.pdf

Steroid receptor interactions with heat shock protein and immunophilin chaperones.

Complementary DNAs (cDNAs) encoding androgen receptors were obtained from human testis and rat ventral prostate cDNA libraries. The amino acid sequence deduced from the nucleotide sequences of the cDNAs indicated the presence of a cysteine-rich DNA-binding domain that is highly conserved in all steroid receptors. The human cDNA was transcribed and the RNA product was translated in cell-free systems to yield a 76-kilodalton protein. The protein was immunoprecipitable by human autoimmune antibodies to the androgen receptor. The protein bound androgens specifically and with high affinity.

https://science.sciencemag.org/content/sci/240/4850/324.full.pdf

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

Much of what I will discuss here today relates to brain differentiation in rodents. This subject was the interest of two outstanding British scientists, Geoffrey Harris and Peter MacDonald. Harris spent his scientific life and considerable intellectual powers observing and enlarging upon this very interesting phenomenon, which was originally described so brilliantly by Carroll Pfeiffer in 1936. Peter MacDonald was an outstanding young man who had already shown the key role of estrogens in central steroid actions by experiments such as the use of antiestrogens to block the action of androgens on brain differentiation, as described below. Geoffrey Harris’ life ended at the pinnacle and fruition of a career that included the elucidation of the neurovascular and chemical links between the brain and pituitary and the isolation of the LH releasing factor. Peter MacDonald's life and continued work were prematurely lost in the recent Paris air disaster; we can only guess what he might have contributed in years to come. However, both of these men left important scientific and intellectual legacies, part of which you have already heard about. If a man's work is what others judge him by, these two will stand up well to any test, any time. We owe them our gratitude and continued remembrance.

The formation of estrogens by central neuroendocrine tissues

In the 20 yr since it was established that impairment of dihydrotestosterone formation is the cause of a rare form of human intersex, a wealth of information has accumulated about the genetics, endocrinology, and variable phenotypic manifestations, culminating in the cloning of cDNAs encoding two 5 alpha-reductase genes and documentation that mutations in the steroid 5 alpha-reductase 2 gene are the cause of 5 alpha-reductase deficiency. Perplexing and difficult problems remain unresolved, e.g. whether the variability in manifestations is due to variable expressions of steroid 5 alpha-reductase 1 or to effects of testosterone itself. It is also imperative to establish whether defects in steroid 5 alpha-reductase 2, perhaps in the heterozygous state, are responsible for a portion of cases of sporadic hypospadias, to determine whether 5 alpha-reductase plays a role in progesterone action in women, and to elucidate the relation between androgen action and gender role behavior.

Steroid 5 alpha-reductase 2 deficiency.

The kinetic parameters, steroid substrate specificity and identities of reaction products were determined for four homogeneous recombinant human 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD) isoforms of the aldo-keto reductase (AKR) superfamily. The enzymes correspond to type 1 3alpha-HSD (AKR1C4), type 2 3alpha(17beta)-HSD (AKR1C3), type 3 3alpha-HSD (AKR1C2) and 20alpha(3alpha)-HSD (AKR1C1), and share at least 84% amino acid sequence identity. All enzymes acted as NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductases and as 3alpha-, 17beta- and 20alpha-hydroxysteroid oxidases. The functional plasticity of these isoforms highlights their ability to modulate the levels of active androgens, oestrogens and progestins. Salient features were that AKR1C4 was the most catalytically efficient, with k(cat)/K(m) values for substrates that exceeded those obtained with other isoforms by 10-30-fold. In the reduction direction, all isoforms inactivated 5alpha-dihydrotestosterone (17beta-hydroxy-5alpha-androstan-3-one; 5alpha-DHT) to yield 5alpha-androstane-3alpha,17beta-diol (3alpha-androstanediol). However, only AKR1C3 reduced Delta(4)-androstene-3,17-dione to produce significant amounts of testosterone. All isoforms reduced oestrone to 17beta-oestradiol, and progesterone to 20alpha-hydroxy-pregn-4-ene-3,20-dione (20alpha-hydroxyprogesterone). In the oxidation direction, only AKR1C2 converted 3alpha-androstanediol to the active hormone 5alpha-DHT. AKR1C3 and AKR1C4 oxidized testosterone to Delta(4)-androstene-3,17-dione. All isoforms oxidized 17beta-oestradiol to oestrone, and 20alpha-hydroxyprogesterone to progesterone. Discrete tissue distribution of these AKR1C enzymes was observed using isoform-specific reverse transcriptase-PCR. AKR1C4 was virtually liver-specific and its high k(cat)/K(m) allows this enzyme to form 5alpha/5beta-tetrahydrosteroids robustly. AKR1C3 was most prominent in the prostate and mammary glands. The ability of AKR1C3 to interconvert testosterone with Delta(4)-androstene-3,17-dione, but to inactivate 5alpha-DHT, is consistent with this enzyme eliminating active androgens from the prostate. In the mammary gland, AKR1C3 will convert Delta(4)-androstene-3,17-dione to testosterone (a substrate aromatizable to 17beta-oestradiol), oestrone to 17beta-oestradiol, and progesterone to 20alpha-hydroxyprogesterone, and this concerted reductive activity may yield a pro-oesterogenic state. AKR1C3 is also the dominant form in the uterus and is responsible for the synthesis of 3alpha-androstanediol which has been implicated as a parturition hormone. The major isoforms in the brain, capable of synthesizing anxiolytic steroids, are AKR1C1 and AKR1C2. These studies are in stark contrast with those in rat where only a single AKR with positional- and stereo-specificity for 3alpha-hydroxysteroids exists.

/pdf/human-3alpha-hydroxysteroid-dehydrogenase-isoforms-akr1c1-52snd8fzjm.pdf

Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.

Receptor Proteins for Androgens ON THE ROLE OF SPECIFIC PROTEINS IN SELECTIVE RETENTION OF 17β-HYDROXY-5α-ANDROSTAN-3-ONE BY RAT VENTRAL PROSTATE IN VIVO AND IN VITRO

Androgen Receptors STEROID AND TISSUE-SPECIFIC RETENTION OF A 17β-HYDROXY-5α-ANDROSTAN-3-ONE-PROTEIN COMPLEX BY THE CELL NUCLEI OF VENTRAL PROSTATE

Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens

Summary Independent studies in several laboratories have strongly indicated that 5α-dihydrotestosterone is one of the active forms of androgen in the sex accessory reproductive glands. In rat ventral prostate and seminal vesicle, there are proteins that bind 5α- dihydrosterone in a highly specific manner. At least two 3H-5α-dihydrotestosterone binding proteins can be isolated from the cytosol fraction of the rat ventral prostate. Only one of the receptor protein-5α-dihydrotestosterone complexes can be retained by prostate nuclei which appear to contain a definite number of nuclear acceptor sites. These processes are highly steroid and tissue specific. Experimental findings leading to these conclusions are recapitulated and discussed in connection with a possible role of 5α-dihydrotestosterone in androgen action.

Senmaw Fang

Papers

Receptor Proteins for Androgens ON THE ROLE OF SPECIFIC PROTEINS IN SELECTIVE RETENTION OF 17β-HYDROXY-5α-ANDROSTAN-3-ONE BY RAT VENTRAL PROSTATE IN VIVO AND IN VITRO

Androgen Receptors STEROID AND TISSUE-SPECIFIC RETENTION OF A 17β-HYDROXY-5α-ANDROSTAN-3-ONE-PROTEIN COMPLEX BY THE CELL NUCLEI OF VENTRAL PROSTATE

Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens

Androgen Receptors: 17β – Hydroxy – 5α – Androstan –3–one and the Translocation of a Cytoplasmic Protein to Cell Nuclei in Prostate

Chapter 10 – Androgen Receptors, Antiandrogens, and Uptake and Retention of Androgens in Male Sex Accessory Organs